Skip to main content
. 2016 Mar 30;22(4):237–245. doi: 10.5761/atcs.oa.15-00239

Table 2.

Postoperative results

  Carperitide group Non-Carperitide group p value

Number 63 65  
Hospital death 1 (1.6%) 8 (12.3%) 0.018
Mortality within 2 years after surgery 6 15 0.055
MACCE within 2 years after surgery 6 21 0.002
Procedure        
 CABG (on pump: OPCAB) 44 (42:2) 41 (40:1)  
 AVR 3 10  
 MVR 0 1  
 Asc-Ao replacement 0 3  
 CABG + valve surgery 12 6  
 CABG + Dor 1 0  
 AVR + Maze 1 0  
 AVR + MVR 0 2  
 AVR + MVR + Maze 0 1  
 AVR + MVR + TAP 0 1  
 AVR + Asc-Ao replacement 1 0  
 AVR + MVR + Asc-Ao replacement 1 0  
Numbers of distal anastomoses 2.68 ± 0.85 2.42 ± 0.99 0.004
ACCT (min) 75.2 ± 63.3 82.7 ± 56.3 0.314
ACCT >90 min 15 (24%) 23 (35%) 0.152
CPBT (min) 141.3 ± 66.3 146.6 ± 64.3 0.530
CPBT >180 min 9 (14%) 18 (28%) 0.063
Dopamine use 47 (75%) 50 (79%) 0.759
Dobutamine use 31 (49%) 34 (52%) 0.726
Epinephrine use 4 (6%) 12 (18%) 0.038
Norepinephrine use 9 (14%) 21 (32%) 0.016
Landiolol hydrochloride 18 (29%) 20 (31%) 0.786
Preoperative AF 2 (3%) 1 (2%) 0.541
POAF 9 (14.8%) 34 (53.1%) <0.0001
Weaning from respirator (days) 1.03 ± 1.15 2.04 ± 3.20 0.022
Resuming dialysis (days) 1.71 ± 0.78 1.27 ± 0.57 <0.0001
Urine volume (Oliguria case)      
 POD 1 312.8 ± 721.0 29.3 ± 89.0 0.002
 POD 2 346.0 ± 808.8 38.8 ± 123.1 0.003
 POD 3 356.1 ± 852.3 35.8 ± 98.6 0.003
Disturbance of consciousness 3 (5%) 6 (9%) 0.323
Hospital stay (days) 15.8 ± 10.0 23.9 ± 24.1 0.015

MACCE: major adverse cardiac and cerebrovascular events; CABG: coronary artery bypass grafting; OPCAB: off pump coronary artery bypass; AVR: aortic valve replacement; MVR: mitral valve replacement; Asc-Ao: ascending aorta; TAP: tricuspid valve annuloplasty; ACCT: aortic cross-clamping tine; CPBT: cardiopulmonary bypass time; AF: atrial fibrillation; POAF: postoperative atrial fibrillation; POD: postoperative day